Cancer Patients, Oncologists Have Discordant Opinions on Prognosis

This article originally appeared here.
Share this content:
Cancer Patients, Oncologists Have Discordant Opinions on Prognosis
Cancer Patients, Oncologists Have Discordant Opinions on Prognosis

FRIDAY, July 15, 2016 (HealthDay News) -- Cancer patients and their oncologists often hold different opinions about the patient's chances for survival and how long they might live, according to a study published online July 14 in JAMA Oncology.

Researchers asked 236 patients with advanced cancer about their prognosis. The 38 oncologists who treated them independently said they would "not have been surprised" if their patients died within a year. The team also asked whether patients knew that their opinions about their prognosis differed from those of their oncologists and the extent to which life expectancy influenced treatment options.

The researchers found that 68 percent of patients rated their odds for survival differently from their oncologists. Almost all patients were more optimistic than their oncologist. Of the 68 percent, only 10 percent understood that their views and their oncologist's differed. Seven out of 10 patients surveyed said they would opt for supportive care rather than aggressive treatment as the end of their lives neared. To make an informed decision, however, patients need to know when death is imminent, the researchers said.

"Our findings suggest that patient-oncologist prognostic discordance is common in advanced cancer and that it is usually due to patients not knowing their oncologists' prognosis opinions," the authors write. "This study supports the urgent clinical and societal need to better understand what it means to communicate well about prognosis to achieve treatment that honors patients' values, preferences, and wishes."

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »